Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$23.82 - $32.8 $50,950 - $70,159
-2,139 Reduced 21.17%
7,964 $219,000
Q4 2023

Jan 04, 2024

SELL
$23.16 - $32.34 $108,249 - $151,157
-4,674 Reduced 31.63%
10,103 $308,000
Q3 2023

Oct 10, 2023

SELL
$31.62 - $45.78 $9,928 - $14,374
-314 Reduced 2.08%
14,777 $467,000
Q2 2023

Jul 06, 2023

BUY
$34.58 - $46.03 $41,046 - $54,637
1,187 Added 8.54%
15,091 $615,000
Q1 2023

Apr 06, 2023

SELL
$33.3 - $44.82 $48,851 - $65,750
-1,467 Reduced 9.54%
13,904 $518,000
Q4 2022

Jan 12, 2023

BUY
$33.21 - $62.69 $26,999 - $50,966
813 Added 5.58%
15,371 $0
Q3 2022

Oct 14, 2022

SELL
$53.92 - $71.7 $3.66 Million - $4.87 Million
-67,941 Reduced 82.35%
14,558 $815,000
Q2 2022

Jul 08, 2022

BUY
$38.49 - $76.21 $2.76 Million - $5.47 Million
71,748 Added 667.36%
82,499 $4.27 Million
Q1 2022

Apr 19, 2022

BUY
$58.27 - $118.99 $94,222 - $192,406
1,617 Added 17.7%
10,751 $781,000
Q4 2021

Jan 12, 2022

BUY
$100.76 - $138.36 $24,988 - $34,313
248 Added 2.79%
9,134 $1.08 Million
Q3 2021

Oct 12, 2021

SELL
$132.37 - $176.78 $48,976 - $65,408
-370 Reduced 4.0%
8,886 $1.19 Million
Q2 2021

Jul 22, 2021

SELL
$60.88 - $161.91 $44,929 - $119,489
-738 Reduced 7.38%
9,256 $1.5 Million
Q1 2021

Jul 22, 2021

BUY
$46.59 - $83.68 $244,830 - $439,738
5,255 Added 110.89%
9,994 $802,000
Q4 2020

Jul 22, 2021

BUY
$18.83 - $63.53 $89,235 - $301,068
4,739 New
4,739 $258,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.6B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.